US PTAB Patent Cases
8,574 decisions indexed
Page 138 of 286 · 8,574 total
Krisp Technologies, Inc. v.Sanas.AI, Inc.
Krisp Technologies has filed an IPR petition challenging Sanas.ai’s U.S. Patent No. 12,125,496 covering neural‑network‑based voice enhancement. The petition asserts that all 20 claims are obvious over a combination of prior‑art references and proposes a specific construction for the term “low‑dimensional representation.”
Comcast Corporation et al. v.Entropic Communications LLC
Comcast has petitioned the PTAB Director to review a decision that found Entropic Communications’ channel‑selection patent invalid. The Patent Owner argues the Board ignored earlier reexamination findings on the same Zhang reference, violating the Director’s memorandum.
Ilooda Co., Ltd. et al. v.Serendia, LLC
Ilooda and Serendia have filed a joint motion to terminate Ilooda’s participation in an IPR over U.S. Patent 10,869,812, citing a settlement of their dispute. The Board has not yet ruled on institution, and the parties also request the settlement be kept confidential.
Comcast Corporation et al. v.Entropic Communications LLC
Comcast opposes Entropic Communications' request to file new exhibits after PTAB final decisions in three IPRs, arguing the request is untimely and unsupported. The board has been asked to deny the request.
CISCO SYSTEMS, INC. v.UMBRA TECHNOLOGIES LTD.
The PTAB denied Cisco's request for Director Review of the institution decision in IPR2024-00270 concerning Umbra's patent.
Apple, Inc. v.THL Holding Company, LLC
Apple’s IPR against THL Holding’s patent 11,350,246 concluded with an adverse judgment after the patent owner disclaimed all challenged claims. The Board entered judgment against claims 20‑27 and terminated the proceeding.
Edwards Lifesciences Corp et al. v.Aortic Innovations LLC
Edwards Lifesciences filed a motion to dismiss an inter partes review of its aortic valve patent, arguing the case is pre‑institution and barred by a prior infringement lawsuit. The Board is asked to terminate the proceeding without a decision.
TransCore LP v.Hand Held Products, Inc.
TransCore and Hand Held Products entered a confidential settlement and jointly moved to terminate IPR2024-00391 concerning U.S. Patent 8,141,784. The Board has not yet decided the merits, and the parties request termination to conserve resources.
Ilooda Co., Ltd. et al. v.Serendia, LLC
Serendia and EndyMed jointly filed a request to keep their settlement agreement confidential under federal law, seeking to separate it from the patent record.
MICROSOFT CORPORATION et al. v.LiTL LLC
The USPTO denied Microsoft’s request for Director review of the PTAB’s decision denying institution of IPR2024-00457 (and the related IPR2024-00458). The denial leaves the institution refusal in place.
Ilooda Co., Ltd. et al. v.Serendia, LLC
Serendia and Jeisys Medical jointly filed a request to keep their settlement agreement confidential under 35 U.S.C. §317(b), seeking to separate it from the patent record.
Jeisys Medical Inc. et al. v.Serendia, LLC
Jeisys Medical settled with SHEnB and Cartessa respondents during its IPR against Serendia, leading to a motion to suspend the schedule.
lululemon usa inc. et al. v.Nike, Inc.
The USPTO denied Lululemon's request for Director Review of the Final Written Decision in IPR2024-00460 concerning Nike's footwear patent 8,266,749. The order contains no substantive analysis of the patent claims.
Jeisys Medical Inc. et al. v.Serendia, LLC
The Board granted a joint motion to terminate the IPR only for Jeisys Medical Inc. after a settlement with Serendia, while EndyMed remains as a petitioner. The settlement agreement was ordered confidential.
Krisp Technologies, Inc. v.Sanas.AI, Inc.
Krisp Technologies has filed an Inter Partes Review petition challenging Sanas.AI’s U.S. Patent No. 11,948,550, which claims a machine‑learning system for real‑time accent conversion. The petitioner alleges obviousness over six prior‑art references and proposes a specific claim construction for “fourth audio data representative of.”
Comcast Corporation et al. v.Entropic Communications LLC
The PTAB Director has received a review request from the patent owner in IPR2024-00446. Comcast may file a 15‑page response limited to the issues raised, with no new evidence allowed.
Comcast Corporation et al. v.Entropic Communications LLC
Entropic Communications has requested Director Review of the IPR involving Comcast’s challenge to patent 11,381,866. Comcast may file a concise, evidence‑free response within five business days, and no additional briefing is permitted.
Datavant, Inc. et al. v.Vigilytics LLC
The PTAB terminated IPR2024-00382 after Datavant and Vigilytics reached a settlement, keeping the agreement confidential.
Samsung Electronics Co., Ltd. et al. v.Advanced Coding Technologies, LLC
Samsung and Advanced Coding Technologies settled their IPR dispute over patent 8,090,025, leading the PTAB to terminate the proceeding. The settlement agreement was treated as confidential business information.
Comcast Corporation et al. v.Entropic Communications LLC
The USPTO Director denied Comcast's request for a Director Review of the Final Written Decision in IPR2024-00441 concerning Entropic Communications' patent 8,792,008.
Datavant, Inc. et al. v.Vigilytics LLC
Datavant and Vigilytics jointly filed a settlement and motion to terminate IPR2024‑00381 concerning patent 10,886,012. The PTAB granted the termination and kept the settlement confidential.
Jeisys Medical Inc. et al. v.Serendia, LLC
EndyMed Medical and Serendia have filed a joint request to keep their settlement agreement confidential under statutory provisions, separating it from the patent record.
Micron Technology, Inc. et al. v.Netlist, Inc.
Micron’s petition to invalidate Netlist’s memory‑module patent was denied by the PTAB because the petitioner could not demonstrate a reasonable likelihood of success on any of the five challenged claims.
Sarepta Therapeutics, Inc. et al. v.Genzyme Corporation et al.
Sarepta filed an IPR petition seeking to invalidate Genzyme’s ’313 AAV detection patent. The petition asserts that all 27 claims are obvious in view of earlier publications on LC‑MS and RP‑HPLC analysis of viral proteins. No secondary considerations are believed to overcome the obviousness argument.
Samsung Electronics Co., Ltd. et al. v.--
Samsung Electronics has filed an IPR petition challenging Whirlpool's 2025 dishwasher patent (US 12,232,681), seeking to invalidate claims 14‑16 and 19 as obvious over prior‑art references Carr, Mailander, and Ochoa.
SAMSUNG ELECTRONICS CO., LTD. et al. v.AQ Corporation
Samsung Electronics has filed an IPR petition challenging AQ Corporation’s U.S. Patent 11,728,564 covering a smartphone antenna module. The petition asserts that all 22 claims are obvious over multiple prior‑art references and seeks cancellation of the claims.
SAMSUNG ELECTRONICS CO., LTD. et al. v.AQ Corporation
Samsung has filed an IPR petition challenging AQ Corp's ’564 smartphone antenna patent, asserting that all 22 claims are obvious over multiple prior‑art references covering dual‑side coil layouts, NFC, MST and wireless charging. The petition seeks cancellation of claims 1‑20 under 35 U.S.C. §311.
Pinterest, Inc. v.--
Pinterest has filed an IPR petition challenging all 20 claims of OpenTV’s ’703 patent, asserting that the claims are obvious over prior art such as Orr, Hsu, Lim, and Hervey.
Google LLC v.--
Google has filed an IPR petition seeking cancellation of all 14 claims of Headwater Research’s ’564 patent covering a mobile device with secure MMS messaging. The petition relies on obviousness arguments combining TS‑23.140, Rakic and several other references.
Cisco Systems, Inc. v.--
Cisco Systems has filed a petition for inter partes review of U.S. Patent 8,780,887, asserting that its ten claims are obvious over the Pankratov prior‑art reference. The petition seeks institution of the IPR and cancellation of the challenged claims.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.